180 related articles for article (PubMed ID: 24646485)
1. The scientific basis of body surface area-based dosing.
Chatelut E; Puisset F
Clin Pharmacol Ther; 2014 Apr; 95(4):359-61. PubMed ID: 24646485
[No Abstract] [Full Text] [Related]
2. Conventional dosing of anticancer agents: precisely wrong or just inaccurate?
Bins S; Ratain MJ; Mathijssen RH
Clin Pharmacol Ther; 2014 Apr; 95(4):361-4. PubMed ID: 24646486
[No Abstract] [Full Text] [Related]
3. Scaling adult dose and schedule of anticancer agents to children.
Dawson TH
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2035-45. PubMed ID: 24072230
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin dosing in children: calculation by different formulae.
Würthwein G; Krefeld B; Gerss J; Boos J
Onkologie; 2011; 34(1-2):16-22. PubMed ID: 21346380
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
Jastaniah W; Aseeri M
J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
[TBL] [Abstract][Full Text] [Related]
6. Deceptive argumentation against diagnostic microdosing of anticancer drugs.
Theile D; Mikus G
Int J Cancer; 2014 Oct; 135(7):1753-4. PubMed ID: 24615734
[No Abstract] [Full Text] [Related]
7. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
Kouno T; Katsumata N; Mukai H; Ando M; Watanabe T
Jpn J Clin Oncol; 2003 Jun; 33(6):309-13. PubMed ID: 12913086
[TBL] [Abstract][Full Text] [Related]
8. [Methods for optimizing cytostatic drug therapy].
Lipp HP
Med Monatsschr Pharm; 1995 Oct; 18(10):282-91. PubMed ID: 7476654
[No Abstract] [Full Text] [Related]
9. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Schmitt A; Gladieff L; Lansiaux A; Bobin-Dubigeon C; Etienne-Grimaldi MC; Boisdron-Celle M; Serre-Debauvais F; Pinguet F; Floquet A; Billaud E; Le Guellec C; Penel N; Campone M; Largillier R; Capitain O; Fabbro M; Houede N; Medioni J; Bougnoux P; Lochon I; Chatelut E
Clin Cancer Res; 2009 May; 15(10):3633-9. PubMed ID: 19401344
[TBL] [Abstract][Full Text] [Related]
10. Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimens.
Loos WJ; Gelderblom H; Sparreboom A; Verweij J; de Jonge MJ
Clin Cancer Res; 2000 Jul; 6(7):2685-9. PubMed ID: 10914710
[TBL] [Abstract][Full Text] [Related]
11. A Cost-Focused Alternative Cancer Medication Dispensing Strategy-"Pack Splitting".
Harvey RD; Ratain MJ
JAMA Oncol; 2019 Dec; 5(12):1691-1692. PubMed ID: 31621807
[No Abstract] [Full Text] [Related]
12. Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.
Lucas CJ; Martin JH
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S78-S98. PubMed ID: 28921641
[TBL] [Abstract][Full Text] [Related]
13. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
14. Body surface area in dosing anticancer agents: scratch the surface!
Miller AA
J Natl Cancer Inst; 2002 Dec; 94(24):1822-3. PubMed ID: 12488468
[No Abstract] [Full Text] [Related]
15. Comparison of two different formulas for body surface area in adults at extremes of height and weight.
Fancher KM; Sacco AJ; Gwin RC; Gormley LK; Mitchell CB
J Oncol Pharm Pract; 2016 Oct; 22(5):690-5. PubMed ID: 26385906
[TBL] [Abstract][Full Text] [Related]
16. Comparison of weight- vs body surface area-based growth hormone dosing for children: implications for response.
Hughes IP; Harris M; Cotterill A; Ambler G; Cowell CT; Cutfield WS; Werther G; Choong CS
Clin Endocrinol (Oxf); 2014 Mar; 80(3):384-94. PubMed ID: 23968547
[TBL] [Abstract][Full Text] [Related]
17. Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents.
Chatelut E; White-Koning ML; Mathijssen RH; Puisset F; Baker SD; Sparreboom A
Br J Cancer; 2012 Sep; 107(7):1100-6. PubMed ID: 22929884
[TBL] [Abstract][Full Text] [Related]
18. Dosing strategies for anticancer drugs: the good, the bad and body-surface area.
Felici A; Verweij J; Sparreboom A
Eur J Cancer; 2002 Sep; 38(13):1677-84. PubMed ID: 12175683
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients.
Cassidy J; Twelves C; Cameron D; Steward W; O'Byrne K; Jodrell D; Banken L; Goggin T; Jones D; Roos B; Bush E; Weidekamm E; Reigner B
Cancer Chemother Pharmacol; 1999; 44(6):453-60. PubMed ID: 10550565
[TBL] [Abstract][Full Text] [Related]
20. To cap or not to cap: chemotherapy dosing in obese adult hematology patients.
Sandhu G; Mapp S; Carrington C; Hennig S
Clin Pharmacol Ther; 2014 Apr; 95(4):356-8. PubMed ID: 24646484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
